title: Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy.
abstract: To our knowledge, we report the first case of improvement of HIV-associated cutaneous CD8(+) pseudolymphoma with highly active antiretroviral therapy. This favors the hypothesis of a reactive cutaneous infiltration by HIV-specific cytotoxic T cells in this disease.
authors.affiliation: Department of Dermatology, Hôpital Saint-Louis AP-HP, Paris, France.
authors.forename: Noël Emile Célestin
authors.initials: NE
authors.lastname: Schartz
authors.forename: Arnaud
authors.initials: A
authors.lastname: De La Blanchardiére
authors.forename: Siham
authors.initials: S
authors.lastname: Alaoui
authors.forename: Patrice
authors.initials: P
authors.lastname: Morel
authors.forename: François
authors.initials: F
authors.lastname: Sigaux
authors.forename: Marie-Dominique
authors.initials: MD
authors.lastname: Vignon-Pennamen
authors.forename: Béatrice
authors.initials: B
authors.lastname: Flageul
authors.forename: Céleste
authors.initials: C
authors.lastname: Lebbé
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D017809:Fatal Outcome; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000188:drug therapy*; D016410:Lymphoma, T-Cell, Cutaneous / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D019310:Pseudolymphoma / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D013226:Status Epilepticus / Q000150:complications